Skip to main content

Adicet Bio, Inc.

ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001720580

No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.

Superinvestors holding ACET, Q2 2026

See all superinvestors

No superinvestor reported holding ACET in Q2 2026.